Organon has acquired regulatory and commercial rights in the United States from Biogen for Tofidence, a biosimilar to Actemra for intravenous infusion. Tofidence, the first approved tocilizumab ...

Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. JERSEY CITY, N.J ...

Organon Pharma UK is aiming to grow capacity and create new jobs at the facility off Shotton Lane. An application by the firm submitted last August was approved by Northumberland County Council ...